Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
CJ Turtle, RD Brown, DE Joshua & DNJ Hart. (2004) DC in multiple myeloma immunotherapy. Cytotherapy 6:2, pages 128-137.
Read now
Read now
Articles from other publishers (35)
Costantino Ricci, Maria V. Altavilla, Barbara Corti, Ernesto Pasquini, Livo Presutti, Anna M. Baietti, Luca Amorosa, Tiziana Balbi, Chiara Baldovini, Francesca Ambrosi, Marco Grillini, Antonia D’Errico, Michelangelo Fiorentino & Maria P. Foschini. (2023) PRAME Expression in Mucosal Melanoma of the Head and Neck Region. American Journal of Surgical Pathology 47:5, pages 599-610.
Crossref
Crossref
Marcello Turi, Anjana Anilkumar Sithara, Lucie Hofmanová, David Žihala, Dhwani Radhakrishnan, Alexander Vdovin, Sofija Knápková, Tereza Ševčíková, Zuzana Chyra, Tomáš Jelínek, Michal Šimíček, Annamaria Gullà, Kenneth Carl Anderson, Roman Hájek & Matouš Hrdinka. (2023) Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling. International Journal of Molecular Sciences 24:6, pages 5623.
Crossref
Crossref
Curtis E. Margo & Hans E. Grossniklaus. 2023. Ophthalmic Pathology. Ophthalmic Pathology
25
31
.
Hisayoshi Hashimoto, Derya Güngör, Naomi Krickeberg, Johanna Schmitt, Larissa Doll, Marina Schmidt, Sabine Schleicher, Elvira Criado-Moronati & Karin Schilbach. (2022) TH1 cytokines induce senescence in AML. Leukemia Research 117, pages 106842.
Crossref
Crossref
Gerardo Cazzato, Katia Mangialardi, Giovanni Falcicchio, Anna Colagrande, Giuseppe Ingravallo, Francesca Arezzo, Giovanna Giliberti, Irma Trilli, Vera Loizzi, Teresa Lettini, Sara Scarcella, Tiziana Annese, Paola Parente, Carmelo Lupo, Nadia Casatta, Eugenio Maiorano, Gennaro Cormio, Leonardo Resta & Domenico Ribatti. (2022) Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study. Genes 13:3, pages 545.
Crossref
Crossref
Maciej Kaczorowski, Małgorzata Chłopek, Anna Kruczak, Janusz Ryś, Jerzy Lasota & Markku Miettinen. (2022) PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors. American Journal of Surgical Pathology Publish Ahead of Print.
Crossref
Crossref
Chau M. Bui, Sumire Kitahara, Wonwoo Shon, Tatsiana Pukhalskaya & Bruce R. Smoller. (2021) Lack of PRAME Expression in Cutaneous T-Cell Lymphomas. Dermatopathology 9:1, pages 11-16.
Crossref
Crossref
Wensi Liu, Haichao Tang, Luanfeng Li, Xiangyi Wang, Zhaojin Yu & Jianping Li. (2021) Peptide‐based therapeutic cancer vaccine: Current trends in clinical application. Cell Proliferation 54:5.
Crossref
Crossref
Maiko Matsushita, Saku Saito, Shinya Yokoe, Daiju Ichikawa & Yutaka Hattori. (2020) Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy. Vaccines 8:4, pages 579.
Crossref
Crossref
Chen Lu, Mingyao Yang, Randall M. Rossi, Aihua Wang, Weber B. Feitosa, Francisco J. Diaz & Wan‐Sheng Liu. (2020)
Deletion of the mouse X‐linked
Prame
gene causes germ cell reduction in spermatogenesis
. Molecular Reproduction and Development 87:6, pages 666-679.
Crossref
Crossref
Jay G. Tanna, Robert Ulrey, Kirsten M. Williams & Patrick J. Hanley. (2019) Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells. Cytotherapy 21:3, pages 278-288.
Crossref
Crossref
Wan-Sheng Liu. (2019) Mammalian Sex Chromosome Structure, Gene Content, and Function in Male Fertility. Annual Review of Animal Biosciences 7:1, pages 103-124.
Crossref
Crossref
Saeed Farajzadeh Valilou & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
61
74
.
Jenny Zilberberg, Rena Feinman & Robert Korngold. (2015) Strategies for the Identification of T Cell–Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-versus-Tumor Responses after Allogeneic Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 21:6, pages 1000-1007.
Crossref
Crossref
M M van Loenen, R de Boer, R S Hagedoorn, V Jankipersadsing, A L Amir, J H F Falkenburg & M H M Heemskerk. (2013) Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells. Gene Therapy 20:8, pages 861-867.
Crossref
Crossref
Bhavesh V. Mistry, Yaqi Zhao, Ti-Cheng Chang, Hiroshi Yasue, Mitsuru Chiba, Jon Oatley, Francisco Diaz & Wan-Sheng Liu. (2013) Differential Expression of PRAMEL1, a Cancer/Testis Antigen, during Spermatogenesis in the Mouse. PLoS ONE 8:4, pages e60611.
Crossref
Crossref
Zhiyong Qiu, David C. Diamond, Kent A. Smith, Dar Rosario, Sabrina Miles, Mihail Obrocea, Thomas M. Kundig & Adrian Bot. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
103
125
.
Riko Kawano, Kennosuke Karube, Masahiro Kikuchi, Morishige Takeshita, Kazuo Tamura, Naokuni Uike, Tetsuya Eto, Koichi Ohshima & Junji Suzumiya. (2009) Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma. Journal of Clinical and Experimental Hematopathology 49:1, pages 1-7.
Crossref
Crossref
Semra Paydas. (2008) Is everything known in all faces of iceberg in PRAME?. Leukemia Research 32:9, pages 1356-1357.
Crossref
Crossref
Jose Roman-Gomez, Antonio Jimenez-Velasco, Xabier Agirre, Juan A. Castillejo, German Navarro, Edurne San Jose-Eneriz, Leire Garate, Lucia Cordeu, Francisco Cervantes, Felipe Prosper, Anabel Heiniger & Antonio Torres. (2007) Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leukemia Research 31:11, pages 1521-1528.
Crossref
Crossref
Barbara-Ann Guinn, Azim Mohamedali, N. Shaun B. Thomas & Ken I. Mills. (2006) Immunotherapy of myeloid leukaemia. Cancer Immunology, Immunotherapy 56:7, pages 943-957.
Crossref
Crossref
A. Spanaki, C. Perdikogianni, E. Linardakis & M. Kalmanti. (2007) Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia. Leukemia Research 31:5, pages 639-642.
Crossref
Crossref
Semra Paydas, Kahraman Tanriverdi, Sinan Yavuz & Gulsah Seydaoglu. (2007) PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature. Leukemia Research 31:3, pages 365-369.
Crossref
Crossref
Barbara-ann Guinn, Azim Mohamedali, Ken I. MillsBarbara Czepulkowski, Michael SchmittJochen Greiner. (2017) Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia. Biomarker Insights 2, pages 117727190700200.
Crossref
Crossref
Yijun Sun, Steve Goodison, Jian Li, Li Liu & William Farmerie. (2007) Improved breast cancer prognosis through the combination of clinical and genetic markers. Bioinformatics 23:1, pages 30-37.
Crossref
Crossref
Daniel H. Fowler, Jeanne Odom, Seth M. Steinberg, Catherine K. Chow, Jason Foley, Yelena Kogan, Jeannie Hou, Juan Gea-Banacloche, Claude Sportes, Steven Pavletic, Susan Leitman, Elizabeth J. Read, Charles Carter, Arne Kolstad, Rebecca Fox, Gregory L. Beatty, Robert H. Vonderheide, Bruce L. Levine, Carl H. June, Ronald E. Gress & Michael R. Bishop. (2006) Phase I Clinical Trial of Costimulated, IL-4 Polarized Donor CD4+ T Cells as Augmentation of Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 12:11, pages 1150-1160.
Crossref
Crossref
S Biade, M Marinucci, J Schick, D Roberts, G Workman, E H Sage, P J O'Dwyer, V A LiVolsi & S W Johnson. (2006) Gene expression profiling of human ovarian tumours. British Journal of Cancer 95:8, pages 1092-1100.
Crossref
Crossref
Nick Goulden, Paul Virgo & David Grimwade. (2006) Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now. British Journal of Haematology 134:3, pages 273-282.
Crossref
Crossref
Kristen J. Radford, Frank Vari & Derek N.J. Hart. (2005) Vaccine strategies to treat lymphoproliferative disorders. Pathology 37:6, pages 534-550.
Crossref
Crossref
Semra Paydas, Kahraman Tanriverdi, Sinan Yavuz, Umut Disel, Fikri Baslamisli & Refik Burgut. (2005) PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects. American Journal of Hematology 79:4, pages 257-261.
Crossref
Crossref
Li Li, Peter Reinhardt, Anita Schmitt, Thomas F. E. Barth, Jochen Greiner, Mark Ringhoffer, Hartmut Döhner, Markus Wiesneth & Michael Schmitt. (2004) Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens. Cancer Immunology, Immunotherapy 54:7, pages 685-693.
Crossref
Crossref
Jan Akervall, Xiang Guo, Chao-Nan Qian, Jacqueline Schoumans, Brandon Leeser, Eric Kort, Andrew Cole, James Resau, Carol Bradford, Thomas Carey, Johan Wennerberg, Harald Anderson, Jan Tennvall & Bin T. Teh. (2004) Genetic and Expression Profiles of Squamous Cell Carcinoma of the Head and Neck Correlate with Cisplatin Sensitivity and Resistance in Cell Lines and Patients. Clinical Cancer Research 10:24, pages 8204-8213.
Crossref
Crossref
Shobhit Gupta, Dorothea Zink, Bernhard Korn, Martin Vingron & Stefan A Haas. (2004) Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing. BMC Genomics 5:1.
Crossref
Crossref
Suzanne McElwaine, Claire Mulligan, Jürgen Groet, Monica Spinelli, Andrea Rinaldi, Gareth Denyer, Afua Mensah, Simona Cavani, Chiara Baldo, Franca Dagna-Bricarelli, Ian Hann, Giuseppe Basso, Finbarr E. Cotter & Dean Nizetic. (2004)
Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing
PRAME
as a specific discriminating marker
. British Journal of Haematology 125:6, pages 729-742.
Crossref
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref
Crossref